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Abstract
Background: Endoscopic treatment for duodenal bulb neuroendocrine tumor larger than 10 mm is still
controversial. This report presents four cases successfully treated with endosonography (EUS)-assisted endoscopic
mucosal resection (EMR) procedure for duodenal bulb neuroendocrine tumor larger than 10 mm in diameter.
Methods: The case series of four patients diagnosed with neuroendocrine tumor from 2003 to 2008 were
reviewed. EUS demonstrated well-defined hypoechoic tumors confined to the submucosal hyperechoic layer and
the underlying hypoechoic muscularis propria was intact in all four patients. EMR were planned and performed for
the duodenal bulb neuroendocrine tumors larger than 10 mm.
Results: En bloc resections with tumor free lateral and basal margins were accomplished using an endoscopic
diathermic snare with forward-viewing instruments without any complications. Neither residual duodenal
neuroendocrine tumors nor metastatic lesions were detected during the observation period ranging 19 to 78
months
Conclusion: Duodenal bulb neuroendocrine, larger than 10 mm in diameter, can be treated by endoscopic
procedure, after confirming that the tumor confined to the submucosal layer in EUS examination, and no lymph
node involvement by abdominal CT and US.
Background
Recently, endoscopic resection of neuroendocrine of the
duodenum is increasingly performed as an alternative to
conventional surgery. Most reports state that duodenal
neuroendocrine tumor can be treated by endoscopic
excision, when the diameter is less than 10 mm and
there is no invasion of the muscularis propria [1]. On
the other hand, others have shown that the features
associated with metastatic risk are a diameter greater
than 2 cm [2], and those with duodenal neuroendocrine
tumor with a diameter larger than 10 mm can be suc-
cessfully treated by endoscopic procedure [3,4]. There-
fore, it is controversial whether endoscopic treatment is
appropriate for duodenal neuroendocrine tumor larger
than 10 mm in diameter. This report describes the
successful EUS-assisted EMR for duodenal bulb neu-
roendocrine tumors larger than 10 mm in diameter.
Methods
The case series of four patients diagnosed with neuroen-
docrine tumor from 2003 to 2008 were reviewed. All
four cases had no symptoms for the tumor. All of them
were evaluated by endoscopic and endosonographic
examination of the upper gastrointestinal tract, whole
abdominal computed tomography (CT), and abdominal
ultrasonography (US). Endoscopic findings showed that
all four cases were characterized by semipedunculated
elevation accompanied by irregularly shaped erythema-
tous central depression (Figure 1). EUS demonstrated
that well-defined hypoechoic tumors confined to the
submucosal hyperechoic layer, and that the underlying
hypoechoic muscularis propria was intact in all four
patients (Figure 2). No other polypoid lesions were
found in the gastrointestinal tract, and no enlarged
lymph nodes were identified in any of the patients on
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nosed histologically as neuroendocrine tumors after
endoscopic biopsy with the standard forceps method.
The surgical indications for duodenal bulb neuroendo-
crine tumor larger than 10 mm in diameter were
explained to all of the patients and all provided
informed consent for endoscopic resection. Thereafter,
EMR were planned and performed for the duodenal
bulb neuroendocrine tumors.
Results
These lesions were fully lifted with submucosal injection
of saline. En bloc resections with tumor free lateral and
basal margins were accomplished using an endoscopic
diathermic snare with forward-viewing instruments
(Olympus GIF 2T-260) without any complications
(Table 1). The histopathological examination confirmed
the diagnosis of neuroendocrine tumors, which con-
sisted of small uniform cells arranged in a ribbon- like
pattern with no mitosis, confined to submucosal layer
for patient 1, 2 and 3, and confined to mucosal layer in
patient 4 (Table 2). All four tumors were endocrinologi-
cally inactive, and diagnosed as neuroendocrine tumor
with positive immunohistochemical staining for chromo-
granin A. These patients were followed up annually by
endoscopy with biopsies and abdominal CT and US.
Neither residual duodenal neuroendocrine tumors nor
metastatic lesions were detected during the observation
period ranging 19 to 78 months (Table 2).
Discussion
Duodenal neroendocrine tumor, formerly termed as car-
cinoid tumor, is rare entity. The tumors is derived from
enterochromaffin cells, and often occurred in gastroin-
testinal tract. Only 2.6% duodenal carcinoid tumors is
reported of all carcinoid tumors in the United States[5].
The rarity makes difficulty to address the feasibility of
the endoscopic treatment for this tumor. Although lar-
ger study is needed to confirm the indication of endo-
scopic procedure for the tumor, small case series like
our study is also important for uncommon tumor.
Surgical resection is generally recommended for neu-
roendocrine tumor due to the risk of lymph node involve-
ment [6]. Endoscopic treatment such as EMR or
endoscopic submucosal dissection is an alternative to con-
ventional surgery including a duodenal resection in
patients with neuroendocrine tumor of the duodenum,
since recent development of endoscopic technology makes
it possible to detect small and early neuroendocrine
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Figure 1 Endoscopic findings of the duodenal neuroendocrine
tumors. A, B, C, D. Semipedunculated elevation accompanied by
an irregularly shaped erythematous central depression (A: patient 1;
B: patient 2; C: patient 3; D: patient 4).
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Figure 2 Endosonographic findings of the duodenal
neuroendocrine tumors. A, B, C, D. Well-defined hypoechoic
tumor confined to submucosal hyperechoic layer and the intact
underlying hyperechoic muscularis propria (A: patient 1; B: patient
2; C: patient 3; D: patient 4).
Table 1 Endoscopic procedure and complications
Case Endoscopic
procedure
Duration of Surgery
(minutes)
Perforation Bleeding
1. diathermic
snare
15 No No
2. diathermic
snare
20 No No
3. diathermic
snare
17 No No
4. diathermic
snare
15 No No
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small duodenal bulb neuroendocrine tumor[1,7-10]. Some
report mentioned that EMR procedure is also useful for
neuroendocrine tumor located on the second portion[11].
Although more case series for duodenal neuroendocrine
tumor is needed, EMR technique is a safety procedure for
small neuroendocrine tumors.
The appropriate indication criteria are needed to per-
form endoscopic treatment, because neuroendocrine
tumor is considered to have malignant potential for
metastasis. Burke described that the features associated
with increased risk of metastasis included involvement
of the muscularis propria, size larger than 20 mm, and
the presence of mitotic figures [2]. Duodenal neuroen-
docrine tumors smaller than 20 mm can be treated
safely with local excision alone [12]. The metastatic
rates of neuroendocrine tumor are proportional to the
size of the tumor: 8.3% with tumors smaller than 5 mm,
10.5% with tumors between 5.1 and 10 mm, 17.4% with
tumors between 10.1 and 15 mm, and 8.8% with those
between 15.1 and 20 mm [13]. Therefore, if neuroendo-
crine tumor smaller than 20 mm in diameter is diag-
nosed to be localized within the submucosal layer by
EUS examination, endoscopic resection may be one of
the option for the treatment.
Preoperative EUS, examining not only the depth of
tumor but also lymph node involvement, is an impor-
tant modality for determination of endoscopic respect-
ability, when neuroendocrine tumor larger than 10 mm
in diameter is evaluated for the surgical options [7,9],
since neuroendocrine tumor with invasion to the mus-
cularis propria is associated with metastasis. Meanwhile,
it is recommended that full-thickness resection of
lesions in the gastrointestinal tract should be performed
if the neuroendocrine tumor has extensively infiltrated
the submucosal layer or involves the muscle layer,
because conventional EMR does not eliminate the possi-
bility of tumor seeding in the vertical margin due to the
burning effect[14,15]. Therefore, endoscopic resection
must be performed, after confirming that the tumor is
confined to the submucosal layer and there is no metas-
tasis. Moreover, endoscopic treatment must be followed
by histopathological examination confirming that addi-
tional surgical treatment is required or not. In the cur-
rent series, histopathological investigations supported
that EUS assisted EMR can be performed safely and
completely.
Conclusions
The present report described that four patients with
duodenal neuroendocrine larger than 10 mm in dia-
meter could be endoscopically resected. There was no
evidence of residual tumor and metastasis during the
follow up period ranging 19 to 78 months. Further fol-
low-up is required to address this technique is safely for
long-term outcome of neuroendocrine tumors[16]. After
confirming that the tumor confined to the submucosal
layer by EUS examination, and no lymph node involve-
ment by abdominal CT and US, duodenal bulb neuroen-
docrine tumor, larger than 10 mm in diameter, can be
treated by endoscopic procedure.
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